Dr. Graber
Objectives
![]()
-Refresh the knowledge on the major buffer systems in the extra- and intracellular compartments and their regulation.
-Learn to operate the Henderson-Hasselbach equation in the pH and [H+] mode (non-logarithmic mass-action equation) and to calculate deficits.
-Learn and understand the major causes leading to disorders of acid-base metabolism.
-Learn to interprete the plasma and urinary parameters characterizing acid-base
metabolism and to apply different therapetics to correct the abnormalities.
INTRODUCTION
Human
physiology has evolved to maintain ECF pH at a value of 7.40, a value
physicians (but not chemists!) regard as “neutral”. Perturbations in the acid direction produce “acidemia”, which
becomes life threatening at values below 7.0.
Alkalemia produces comparable morbidity at values over 7.8. The acute toxicity of acid-base derangements
will primarily involve the heart and brain.
Chronic acid-base disorders also produce problems. For example, chronic metabolic acidosis
retards growth in children, and leads to osteomalacia by the gradual dissolution
of bone from the titration of bone base by H+.

The
imidazole nitrogen of histidine, and the nitrogen of the N-terminal amino acid
of proteins titrate ver the physiologic range of pH. These titrations change the structure, and therefore the function
of these proteins. The proteins
involved may be structural, transport protents, receptors, hormones, enzymes,
hemoglobin, etc. pH therefore affects essentially every aspect of cell
Function
by altering the structure of proteins and in some instances substrates,
cofactors etc.
THE HCO3/CO2 BUFFER SYSTEM Acid-base homeostasis centers around the regulation of the HCO3-/CO2 buffer system. Three key features of this buffer make it ideal for this purpose:
1) It is the buffer present at the highest concentrations in the body;
2) It’s pK value of 6.1 is close enough the physiologic pH to make it a good buffer; and
3) The major components of the buffer can be independently regulated by the lungs (CO2) or Kidneys (HCO3-)
Because acid-bas regulations centers on the HCO3-/CO2 buffer pair, all acid-base disorders are classified as being either respiratory (too much/too little CO2) or metabolic (too much/too little HCO3-). The equations relating the components of the HCO3-/CO2 buffer system are shown. With these equations you can calculate one parameter knowing the other two.

ACID-BASE BALANCE Acid-base balance means that the net quantity of acid or base we ingest is quantitatively excreted by the lungs and kidney. In this case we are in balance, the systemic pH will be stable, and the body buffers preserved. These are the major physiologic acid/bases:
|
|
|
Acid |
|
Base |
|
|
|
|
|
|
|
MINERAL |
|
H+ |
|
OH- |
|
|
|
HCl |
|
NH3-- |
|
|
|
H2SO4 |
|
SO4- |
|
|
|
H2PO4 |
|
HPO4- |
|
|
|
|
|
|
|
ORGANIC |
|
CO2 |
|
HCO3- |
|
|
|
LACTIC ACID |
|
LACTATE- |
|
|
|
b-HYDROXYBUTYRIC ACID |
|
b-HYDROXYBUTYRATE- |
With a normal caloric intake of a meat-based diet the average person will generate approximately 20,000 mEq of acid/day in the form of CO2 as the end-product of carbohydrate and fat metabolism. This CO2 will be excreted by the lungs. Protein catabolism produces about1 mEq/kg (50-60 mEq/day) of inorganic acids (like sulfuric, phosphoric, or hydrochloric acids) which must be excreted by the kidney. To excrete this 50-60 mEq/day of acid into the final urine the kidney has to actually secrete 4370 mEq/day of acid: Most of this is used to titrate the filtered load of base (24 mEq/L HCO3- x 180 L/day = 4320 mEq/day), and only after this base has been titrated can net acid excretion be accomplished. Net acid excretion (NAE) is defined as:
NET ACID EXCRETION = NH4Cl + titratable acid – HCO3-
The titrable acid is the amount of base needed to return the urine pH back to the systemic pH, and represents mostly the amount of H2PO4 in the urine. In general, whenever the urine pH is > 7 NAE will be zero or even negative because HCO3- will be present, all of the NH4Cl will have been titrated to NH3 and reabsorbed, and H2PO4 will have been titrated to HPO4-. If the urine pH is <6, NAE will always be positive because the HCO3-concentration at this pH is <1 mEq/L.
THE RESPONSE TO AN ACID-BASE CHALLENGE has three components:

Buffering: All acid or base
challenges are buffered. In the ECF
this is predominantly by the HCO3-/CO2 buffer
system, and inside cells the major buffers are proteins and PO4. Buffering reactions are instaneous and
extremely effective: as shown in the figure, an acid load sufficient to reduce
an unbuffered solution to a pH less than 2 only reduces the blood pH of an
animal by 0.3 pH units.
Compensation: Respiratory disorders evoke a compensatory renal response which will tend to correct the pH back towards normal. Metabolic disorders evoke a respiratory compensatory response.
Compensation is very important is maintaining a systemic pH compatible with life. Consider a severe metabolic acidosis which reduced HCO3- levels to 5 mEq/L. A normal respiratory response will be to increase ventilation, blow off CO2, and reduce pCO2 levels to approximately 18 mm Hg (see nomogram). The resulting pH is 7.07. If there had been no respiratory compensation the pCO2 would remain at its normal value of 40, with a resulting pH of 6.70. The respiratory compensation therefore converts a life-threating degree of acidemia to much more tolerable level.
Correction: In metabolic acidosis or alkalosis the kidney can increase net acid or base excretion to correct the primary abnormality. Respiratory disorders have to be corrected by normalizing lung function and ventilation.
To illustrate how these three factors participate in regulating systemic pH, consider the response to a chronic metabolic acid load. Perturbations are first minimized by buffering, and because this happens essentially instantaneously, we see only the end result in the blood gas pattern. The fall in pH then directly stimulates the peripheral and eventually the central chemoreceptors, resulting in hyperventilation and a further improvement in systemic pH as the respiratory compensation reduces pCO2 levels. Finally, the kidney will begin to correct the disorder by increasing net acid excretion As shown in the figure, this involves an adaptive increase in renal NH3 production over several days. Whereas a normal person might be able to excrete perhaps 150 mEq/day of acid in response to an acute acid load, the adaptive response enables NAE to approach 500-600 mEq/day in chronic metabolic acidosis.

EVALUATION OF
ACID-BASE DISORDERS
History/Physical The history is extremely important. Ask about loss of base (diarrhea) or acid (emesis). Get a thorough drug history. Always think about the patients known medical problems and how they might be acting to produce acid-base disorders by changing ECF volume, K+, aldosterone, etc. Physical exam should include evaluation of ECF volume (edema, turgor, postural BP, neck veins, rales), ventilation, and reflexes.
Arterial blood gases are essential to define acid-base abnormalities. The expected arterial for normal patients are shown. Always be on the lookout for blood drawn instead from the venous system, which will reveal hypoxemia and a respiratory acidosis from the CO2 produced by tissues. The table below shows the pattern seen in the primary acid-base disorders.

The Four Primary Acid-Base Disturbances
|
Type of Disturbance |
Primary Alteration |
Secondary Response |
Mechanism of Secondary Response |
|
Metabolic acidosis |
Decrease in plasma [HCO3-] |
Decrease in Pa CO3 |
Hyperventilation |
|
Metabolic alkalosis |
Increase in plasma [HCO3-] |
Increase in PaCO3 |
Hypoventilation |
|
Respiratory acidosis |
Increase in PaCO3 |
Increase in plasma [HCO3-] |
Acid titration of tissue buffers; transient increase in acid excretion and sustained enhancement of HCO3- reabsorption by kidney |
|
Respiratory alkalosis |
Decrease in Pa CO3 |
Decrease in plasma [HCO3-] |
Alkaline titration of tissue buffers; transient suppression of acid excretion and sustained reduction in bicarbonate reabsorption by kidney |
Urine pH is usually acid, in the range of 5-6.5. This reflects the ongoing secretion of H+ by the kidney to excrete the daily acid load. The urine pH should always be checked in patients with acid-base disorders to be sure if the renal response is appropriate. With normal renal function, anyone with metabolic acidosis should have a very low urine pH, unless the kidneys are the cause of the acidosis as in renal tubular acidosis. Likewise, the urine should be maximally alkaline after infusing HCO3- to produce metabolic alkalosis, unless the kidneys are the cause of the alkalosis, as happens very commonly in the alkalosis associated with vomiting or volume depletion.
An alkaline urine pH is seen in several circumstances: This may occur physiologically whenever the filtered load of HCO3 exceeds the renal threshold. This happens after eating, as the “alkaline tide” from gastric acid secretion raises blood HCO3- enough to produce a urine pH around 8 due to NH3 formation. Urine left sitting usually has an alkaline pH due to CO2 loss. Strict vegetarians also have an alkaline urine.
The acid-base nomogram The acid-base nomogram illustrates the blood gas pattern that are seen when the various primary acid-base disorders are reproduced in otherwise normal patients. A simple acid-base disorder will produce a blood-gas pattern that falls in the shaded areas, and these responses reflect normal buffering and compensation. Another way of judging whether the buffering and compensatory responses are appropriate is to use the rules of thumb which have been derived from the nomogram.

Rules of Thumb for Bedside Interpretation of Acid-Base Disorders
|
Metabolic acidosis |
PaCO2 should fall by 1.0 to 1.5 X the fall in plasma HCO3- concentration |
|
Metabolic alkalosis |
PsCO2 should rise by 0.25 to 1.0 X the rise in plasma HCO3- concentration |
|
Acute respiratory acidosis |
Plasma HCO3- concentration should rise by about 1 mmole per liter for each 10 mm Hg increment in PaCO2 (± 3 mmoles per liter). |
|
Chronic respiratory acidosis |
Plasma HCO3- concentration should rise by about 4 mmoles per liter for each 10 mm Hg increment in PaCO2 (± 4 mmoles per liter). |
|
Acute respiratory alkalosis |
Plasma HCO3- concentration should fall by about 1 to 3 mmoles per liter for each 10 mm Hg decrement in the PaCO2, usually not to less than 18 mmoles per liter. |
|
Chronic respiratory alkalosis |
Plasma HCO3- concentration should fall by about 2 to 5 mmoles per liter per 10 mm Hg decrement in PaCO2 but usually not to less than 14 mmoles per liter. |
PLASMA ELECTROLYTES AND THE ANION GAP Plasma electrolytes are essential in unraveling acid-base disorders for two reasons. First, they reveal characteristic electrolyte patterns: a good example is the hypokalemia that accompanies many types of metabolic alkalosis. The second piece of useful information from the plasma electrolytes is the anion gap, which normally has a value of 12 ± 2 mEq/L.

The gap reflects unmeasured anions, mostly the negative charge on albumin. The gap is used to differentiate metabolic acidosis caused by loss of HCO3- (normal gap) from acidosis caused by organic acids like ketoacids, lactic acid, or toxins like ethylene glycol, or methanol.
In the case of HCO3- loss from RTA, HCO3- is lost in the urine in exchange for Cl. This results in hyperchloremia, the sum of Cl+ HCO3 stays normal, as does the anion gap. In contrast, when metabolic acidosis is due to ingestion or production of any acid other than HCl, the anion gap will increase. This is because the H+ is accompanied by an unmeasured anion (lactate, acetoacetate , etc.) which replaces the HCO3- lost from titration. The sum of Cl + HCO3 will therefore fall, causing the anion gap to increase.
Urinary anion gap = Urine net charge The kidney achieves acid/base balance by secreting NH4+. A normal person excretes 20-50 mEq per day, and this amount should increase to 200-500 mEq/day with chronic acidosis. Unfortunately, the lab does not measure NH4+. We therefore have to estimate the amount of NH4+ in the urine indirectly, by calculating the urinary anion gap, also know as the urine net charge. There is essentially no HCO3 in acid urine, so chloide is essentially the only anion present (unless the patient is excreting ketoacids). Therefore:

REGULATION OF CO2 (Read also the separate article in the syllabus)
Plasma CO2 is determined by the rate of metabolic CO2 production and by alveolar ventilation:
pCO2 = CO2 production x .84
alveolar ventilation
Although respiratory acid-base
disorders can be produced by changes in CO2 production, in
clinical practice disturbances of alveolar ventilation are much more commonly
the cause. As diagrammed on the right,
alveolar ventilation is determined by properties of the lung itself, by the
CNS, and by the neuromusculature involved in breathing. The chemoreceptor system provides feedback regulation of alveolar
ventilation. Ventilation is stimulated
by hypoxemia < 60 mm Hg, by hypercapnea and by acidosis, as seen in the
diagram on thelower right.


RESPIRATORY ACIDOSIS represents CO2 retention by the lungs. We generally divide this process into an acute phase (<24 hours) and more chronic phases. During the acute phase you will see the buffering response (HCO3- will increase about 1 mm for every 10 mm Hg increase in CO2) but there has not yet been time for a renal response. Over the next few days renal acidification is stimulated by the increased pCO2, and by about the 4th day the fully-compensated picture emerges with HCO3- rising u to 4mm/10mm Hg increase in pCO2.

RESPIRATORY ALKALOSIS represents hyperventilation and a primary reduction in pCO2. The acute buffering response will drop HCO3- by about 1-3 mM/10 mm Hg change in pCO2. The more chronic renal response is not well developed, but there is usually a small depression is renal acidification, which will lead to HCO3- wasting and a further decline in blood HCO3- so that the total change is 2-5 mM/10 mm Hg fall in pCO2.

To simplify our thinking about renal acidification we view it as a coordinated 2-step process: The first step is the reclamation of filtered bicarbonate. The second step is “net acid excretion”. As the last diagram illustrates, under normal conditions over 90% of the filtered load of HCO3- has been absorbed by the end of the proximal tubule, and the small amount remaining is reclaimed early in the distal nephron. Reclamation of HCO3- is therefore mostly the function of proximal acidification. Once HCO3- reclamation has taken place and HCO3- concentrations are low enough in the nephron, secreted H+ can be used to titrate NH3 and HPO4- to form “net acid excretion”. This process requires very high luminal H+ concentrations, which are only obtainable in the collecting duct.
The proximal system behaves as if there were a threshold for HCO3- reabsorption, as shown in the following figure. The kidney can reabsorb filtered HCO3- up to plasma values of approximately 24-27 mEq/L, at which point the proximal system is saturated and all filtered HCO3- is excreted quantitatively. There are 3 important corrolaries that follow from this:

The U-B pCO2 gradient Even though there can be no “net acid excretion”, it is important to realize that distal H+ secretion is still taking place at times when plasma HCO3- is elevated and large amounts of HCO3- are being excreted in the urine. The ongoing distal acidification can be detected and quantitated by measuring the pCO2 tensions in the urine. These pCO2 levels will rise substantially above plasma pCO2 as the secreted H+ reacts with HCO3- in the tubular fluid, forming carbonic acid and hence CO2 and H2O.
Acidification takes place along the proximal and distal tubules, the thick ascending loop of Henle and the collecting duct. The thin loop of Henle doesn’t acidify that we know of and in fact may allow a bit of HCO3- backleak. An overview of the entire process is shown below, along with the pH and HCO3- at the various sites determined by micropuncture measurements, and the calculated net acid value. This net acid value starts out with a very large negative value, reflecting the amount of filtered HCO3-. We generally think of renal acidification as being divided into “proximal” and “distal” systems, each with unique features and mechanisms of proton secretion. This is a major oversimplification because the precise mechanism of acidification is different in the loop, the convoluted distal tubule, and in the cortical , outer and inner medullary collecting ducts. In fact, parts of cortical collecting duct can be shown to secrete HCO3- instead of acid if metabolic alkalosis is induced!

PROXIMAL ACIDIFICATION The high-capacity system responsible for over 90% of renal acidification is located in the proximal tubule. Proximal cells possess a large luminal surface area provided by the brush border. This membrane contains both carbonic anhydrase and the Na/H exchange protein which acidifies the lumen. This exchanger is driven by the sodium gradient from lumen (140 mM) to cell (10 mM). The very low values of cell Na arise from the actions of the basolateral Na/K ATPase which is constantly pumping Na out of the cell and K in. For each Na entering the cell from the urine, one H+ is exchanged into the urine. This H+ titrates one HCO3- to carbonic acid, which under the catalysis of carbonic anhydrase present on the brush border dissociates to CO2. The CO2 is freely permeable, and diffuses from the lumen to the cell. The reaction here runs in reverse, to produce H+ (which can recycle across the luminal membrane) and HCO3-, which leaves the cell through the basolateral membrane to enter the blood and regenerate the blood HCO3- levels. The proximal tubule is considered a “leaky” epithelium, and cannot sustain large transtubular gradients of electrical potential or pH. In fact, if the tubular fluid is artificially acidified to values below 6.5 acidification ceases because there are now higher H+ concentrations in the lumen than in the cell, offsetting the chemical driving force generated by the Na gradient. The primary function of the luminal carbonic anhydrase is to prevent the accumulation of carboinic acid; buildup of this H2CO3 would tend to shut off acidification by this effect.

DISTAL ACIDIFICATION After proximal acidification has effectively reabsorbed >90% of the filtered load of HCO3- the distal nephron can effectively secrete the final 50-60 mEq/day of acid needed to maintain balance. This is accomplished by the low-capacity but very potent H+ - ATPase present in the luminal membrane of a-type intercalated cells which is capable of secreting H+ to form up to a 1000 – fold H+ gradient from cells to urine (= 3 pH units). This secreted H+ titrates HPO4= to H2PO4- and traps NH3 as NH4+. Net renal acidification is therefore quantitated as the sum of excreted NH4+ and titratable acid (H2PO4-) minus HCO3- and the latter term in acid urine is essentially zero. Distal acidification can therefore be measured in acid urine as the NAE, and in alkaline urine as the pCO2 gradient between urine and blood. Recently, an H+ pump resembling the electroneutal gastric H/K – ATPase has been identified in some parts of the collecting duct, and this pump may contribute to renal H+ secretion. HCO3- secreting b-cells also exist in the distal nephron, but their role in renal acid/base secretion is not clear.
The distal H+ pump is electrogenic, in contrast to the proximal Na/H exchanger which is electroneutral. This makes the distal system sensitive to electrical potential gradients, which can have important effects on urinary acidification. For example, active Na reabsorption at this site carries positive charge into the cell which will tend to augment H+ secretion by making the cell more positive, the lumen more electronegative. Likewise nonreabsorbable anions tend to augment distal H+ secretion by making the lumenal PD more negative relative to the cell interior. H+ secretion can also be stimulated by aldo or K depletion.

ECF volume: As outlined in previous lectures, the proximal nephron is very sensitive to the ECF volume state. In general, ECF volume depletion augments proximal reabsorption of practically all electrolytes, while ECF expansion depresses reabsorption. This seems to be true for the electrolytes handled by the Na/H exchanger: ECF depletion seems to augment both Na reabsorption and H+ secretion. This will augment acidification and HCO3- reabsorption. ECF expansion conversely depresses proximal acidification and HCO3- will be dumped in the urine because it will escape the proximal nephron and overwhelm the low-capacity distal system.
CO2: Proximal acidification is also increased by CO2, as seen in the figure below on the left. This mediates the renal compensation for respiratory acidosis. Likewise, the renal response to respiratory alkalosis is mediated by a decline in proximal neprhon acidification in response to the low pCO2.
K+: As shown in the figure on the right, proximal acidification is also sensitive to K+. This may be relevent to metabolic alkalosis, in which proximal acidification is commonly increased, in part because of coexisting hypokalemia.
Misc. Proximal acidification is also affected by PTH, angiotensin, and systemic pH.

REGULATION OF DISTAL ACIDIFICATION Distal acidification is primarily thought to be regulated by aldosterone, which augments both H+ and K+ secretion. The distal system is also sensitive to systemic pH, pCO2, and K+. The electrogenicity of distal H+ secretion, as discussed above, makes acidification sensitive to Na handling: anything which increases distal delivery of Na or nonreabsorbable anions will tend to increase H+ secretion. Finally, the diuretic furosemide is a potent stimulator of the distal system, and in fact a standard test of how well the kidney acidifies is to measure net acid exretion after a dose of furosemide.
METABOLIC ACIDOSIS
Metabolic acidosis is defined as a primary reduction in plasma HCO3. This will produce acidemia in the arterial blood gas (unless there is another primary disorder which is more dominant!). The response to metabolic acidosis is outlined below. The addition of acid is first buffered by HCO3 and other buffers. If the respiratory response is appropriate, ventilation will be stimulated. Overall, the pCO2 will be reduced by 1-1.5 mm Hg per mEq/L fall in HCO3. The renal response is to begin augmenting renal H+ secretion to clear the acid load and restore the normal body buffer composition. Note that in metabolic acidiosis the plasma HCO3 is low, and therefore the filtered load of HCO3 will be reduced. We therefore believe that the renal response involves primarily the distal acidification system, because if anything the proximal system has less of an H+ load to secrete. Renal H+ excretion will increase from normal values to 50-60 mEq/day to values an order of magnitude higher over several days. Because the renal excretion of phosphate is essentially stable, this increased NAE is largely in the form of NH4+.
RESPONSE TO METABOLIC ACIDOSIS
BUFFERING: HCO3-
NON-HCO3- BUFFERS: PROTEINS
H+ + HCO3- « CO2
PROTEIN « H-PROTEIN+
RESPIRATORY RESPONSE:
CNS ENTRY OF CO2 ® ¯ pH
STIMULATION OF VENTILATION
CO2 FALLS BY 1-1.5 MM Hg / mEq/L CHANGE IN HCO3-
RENAL RESPONSE:
DISTAL ACIDIFICATION ® NET ACID EXCRETION
URINE pH MAXIMALLY ACID (<5.5
Chronic metabolic acidosis is dangerous because of progressive bone lysis and in children, growth retardation. Chronic metabolic acidosis should always be treated to prevent the resulting osteomalacia and restore growth. Acute metabolic acidosis is dangerous because it produces vasodilation and hypotension, and lowers the myocardial threshold for ventricular fibrillation. Treatment is necessary when the plasma HCO3 falls below 15 mEq/L, and levels below10 should be considered an emergency. Remember that at HCO3 levels below 10 very small changes of HCO3 or pCO2 levels will produce very drastic reductions in pH. Keep in mind that certain types of metabolic acidosis result in the accumulation of organic anions which can be metabolized to HCO3 if the underlying problem is treated (DKA lactic acidosis in particular). Treatment with HCO3 should not be overly aggressive in these cases, or it will produce an overshoot alkalosis.

INCREASED GAP METABOLIC ACIDOSIS represents the addition of some acid other than HCl to the body, and should be considered a medical emergency because the differential diagnosis includes the ingestion of toxins that can result in severe organ damage if the diagnosis is missed. In all these disorders the anion gap is increased because HCO3 is titrated by the acid’s proton but the accompanying anion is usually not measured on the routine set of electrolytes. To make the diagnosis therefore requires trying to exclude renal failure, measuring ketoacids in urine and blood, and doing a thorough urinalysis and fundoscopic exam to detect ethylene glycol ingestion (produces oxalate crystals) or methanol ingestion (produces optic nerve hyperemia than ischemia). The ingestion of toxins can be assumed if there is a substantial osmolar gap. This is the difference between the osmolarity you calculated from the standard formula (estimated osm = 1.9 Na + Glu/18 + BUN/2.8 + 9) and the measured osmolality. Ingested ethanol, methanol, or ethylene glycol will result in a large osmolar gap, and the specific diagnosis can then be established by requesting an emergency screen of the urine for volatile toxins. (Please remember the “volatile” part – if you simply request a “toxic sceen” all you’ll get is testing for sedatives /narcotics!).
Some specific details on the various types of increased gap acidosis are presented below:
The acidosis of renal failure represents the inability to generate the required 1 mEq/kg of H+ NAE because there simply aren’t enough nephrons. The remaining nephrons work well, and the urine will therefore be maximally acid (pH < 6). The patient cannot maintain acid-base balance and will progressively titrate bone buffers until dialysis is started.

Diabetic ketoacidosis represents the accumulation of eta-hydroxybutyric acid and aceto-acetic acids. As diagrammed below chese accumulate as a result of the metabolic effects of insulin deficiency: there is increased lipolysis with release of fatty acids, and the acetyl-CoA endproducts cannot be effectively utilized in the Krebs cycle. The acetyl-CoA is therefore shunted to produce the ketoacids, which accumulate because of an associated defect in utilizing these substrates.
The diagnosis of DKA can be made by finding metabolic acidosis in the setting of hyperglycemia and an elevated anion gap. The dagnosis should always be confirmed by demonstrating “ketones” in the blood or urine using standard bedside tests. These tests use nitruprusside to detect ketone bodies and react substantially with acetone and acetoacetate but negligibly with beta-hydroxybutyrate. The test for ketones can actually be negative in some patients who have a severely deranged redox state and are producing predominantly beta-hydroxybutyrate.


Ethylene glycol ingestion produces acidosis by metabolism of the compound to oxalic acid (producing envelope-like crystals in the urine), and other acids. Ingestion is a true medical emergency because the kidney is rapidly and irreversibly damaed by the metabolites of ethylene glycol, and because the treatment is extremely effective in preventing this. Ethanol is given to produce legally drunk levels of 100 mg/ml, and at these concentrations ethanol serves as the preferred substrate for the alcohol dehydrogenase enzyme that otherwise would convert the ethylene glycol to the more toxic breakdown products. This allows enough time for hemodialysis to be performed which directly removes the ethylene glycol. The diagnosis should be suspected in every patient with an unexplained increased-gap metabolic acidosis, especially alcoholics. The diagnosis should be pursued (by obtaining a stat urinary screen for volatile toxins) if the urine contains oxalate crystals, or if there is an osmolar gap in the plasma.
EHYLENE GLYCOL POISONING
SOURCE: ANTIFREEZE
PATIENT: ALCOHOLIC, RAN OUT OF ETOH
TOXICITY: 100 ml LETHAL; METABOLIZED TO OXALIC ACID, OTHER ACIDS
CLINICAL: EARLY: CRYSTALURIA, CNS (DRUNK, SOMMOLENT, COMA)
METABOLIC ACIDOSIS WITH ELEVATED ANION GAP
MID: PULMONARY EDEMA OR CONGESTION
LATE: ACUTE RENAL FAILURE
TREATMENT: ETOH
IMMEDIATE DIALYSIS

Methanol ingestion is equally toxic because the metabolites (formic acid) damage the optic nerve producing blindness. Suspect methanol ingestion if there is the characteristic odor on the breath, if there are any compliants of visual disturbances or any fundoscopic abnormalities, or if there is an osmolar gap. As in the case of ethylene glycol poisoning, the toxicity is entirely preventable if treatment (ETOH, dialysis) is started early.

Lactic acidosis results from overproduction of lactate by muscle combined with inadequate lacatate removal by the liver and kidney. The diagnosis is made by measuring elevated lactate levels in patient who has negative ketone measurements and no osmolar gap. The treatment rests on reversing the underlying disorder, and using HCO3 therapy to keep systemic HCO3- levels over 10-15 mEq/L.
Dichloroacteate is an experimental drug which increases hepatic pyruvate utilization, thus consuming lactate. The drug appears to be neurotoxic and human trials my not be allowed.

HYPERCHLOREMIC METABOLIC ACIDOSIS represents the loss of HCO3 from either the kidney (renal tubular acidosis = RTA) or the GI tract. In either case the HCO3 is lost in exchange for Cl-. This results in hyperchloremia, and a normal gap because each lost HCO3 is replaced by Cl-. Keep in mind that diarrhea is probably several thousand times more common than RTA and that the diagnosis of diarrhea should be clear from the patient’s history! If for some reason the history could not be obtained, the urinary findings should clearly distinguish whether the HCO3 loss is from the kidney or GI tract: with GI loss of HCO3, the normal kidney sees a systemic metabolic acidosis and will augment both proximal and distal acidification to increase net acid acid excretion. This will tend to correct the acidemia, because each additional h+ excreted returns one HCO3 to the blood to restore the deficit. The urine should therefore be acid (pH < 6) with generous amounts of NH4Cl. Urinary NH4 can be estimated by calculating the urinary anion gap as Na + K – Cl. Because of the high concentrations of the unmeasured caton NH4+, the urinary anion gap is negative in patients with metabolic acidosis due to acid ingestion or from GI loss of HCO3. In contrast, in distal RTA the urine is usually not as acid (pH is > 6.0) and the anion gap is near 0 or positive because of the inability to trap NH3 in the urine. The urinary anion gap will not be much help in detecting proximal RTA, and you will get a clue if this is the problem when you correct the acidosis with HCO3 and see massive HCO3 wasting as you approach normal levels of plasma HCO3.

RENAL TUBULAR ACIDOSISMetabolic acidosis can originate from renal defects in acid secretion, resulting in renal tubular acidosis (RTA). All types of RTA produce a systemic metabolic acidosis with a normal anion gap. Serun k+ is often high or low, depending on the type of RTA. Remember that the normal function of the renal acidificaiton system is to first reclaim all of the filtered HCO3, and to then form the 50-60 mEq/day of net acid that will keep us in balance. In RTA one of these systems is defective.
There are many subtypes of RTA. You are welcome to consult texts for more details on these various types, but we will only expect you to be familiar with proximal RTA and three other RTA’s: Type 4 RTA, classical distal RTA, and hyperkalemic distal RTA. In proximal RTA there is a defect in HCO3 reclamation. In the other three disorders metabolic acidosis results because we are unable to form the necessary amounts of NAE. You can distinguish the various types of RTA by measuring the plasma K, by observing the urine pH at the time of acidosis, and then by observing the response to a HCO3 infusion sufficient to normalize the plasma HCO3 concentration

Proximal acidification: is tested by measuring the HCO3 threshold. At what level of plasma HCO3 do you start to see bicarbonaturia? The normal threshold is at the normal plasma concentration of 22-26 mEq/l. Patients with proximal RTA have reduced thresholds, and if their HCO3 is artificially raised to normal levels they will have massive HCO3 wasting, usually around 10% of filtered load. Patients with other types of RTA will only waste 1-3% when plasma HCO3 is normal.
Distal acidification: is tested by checking the urinary pCO2 at a time when the urine is highly alkaline during the HCO3 infusion. A normal person with intact distal H+ secretion will generate a urinary pCO2 of 60-100 mm Hg. Patients with proximal RTA will do the same, but patients with classical or hperkalemic types of distal RTA will have a urinary pCO2 equal to plasma levels. Patients with Type 4 RTA generally elevate urinary pCO2 as well as normal

PROXIMAL RTA = TYPE II RTA In proximal RTA there is a defect in HCO3 reclamation. This defect causes a reduction in the renal HCO3 threshold. Recall that a normal individual secretes over 4000 mEq/day of H+ proximally to reclaim filtered HCO3. A patient with proximal RTA may only be able to reclaim 3000 mEq/day. There will be HCO3 wasting in the urine ( the distal system has very limited reserve and will be swamped by this large HCO3 load) producing a systemic acidosis. Blood HCO3 concentration will continue to fall until the new threshold value is reached. At this point, the proximal nephron can handle the reduced filtered load normally, which sets the stage for normal distal acidification as well. It is therefore handy to think of proximal RTA as having two stages
: When plasma HCO3 is at normal concentrations of 22-26 mEq/L there will be massive HCO3 wasting (> 10% of filtered load), the urine will be highly alkaline with a high pCO2 (because the distal acidification system is intact and working ok). After a steady state has been achieved the patient will have a stable metabolic acidosis with a plasma HCO3 concentration of 16-20 mEq/L, the urine will be acid, NAE is normal, and therefore the patient is again in acid-base balance.

Patients with proximal RTA are typically hypokalemic because of renal K wasting. This results for the large loads of Na and HCO3 delivery to the distal nephron, both of which increase distal K secretion. Some patients also have other features of proximal nephron dysfunction (renal defects in the reabsorption of glucose, urate, amino acids, etc), known as the Fanconi syndrome.

CLASSICAL DISTAL RTA = TYPE I is a rather rare disorder and reflects a primary problem in the distal H+ secretion mechanism. The urine pH in this syndrome can never be lowered below 6, and the required amount of NAE can therefore not take place. The defective distal acidification is also revealed whenever the urine is alkaline, because these patients are unable to raise urinary pCO2 above systemic levels.
These patients are never in acid-base balance. The progressive titration of bone buffer results in osteomalacia, and renal calcium stones. Fortunately, oral HCO3 therapy at the expected 50-60 mEq/day fully treats the acidemia and restores acid-base balance.

HYPERKALEMIC DISTAL RTA is also quite common, and should be thought of whenever urinary tract obstruction is a possibility, or if the patient has sickle cell disease, amyloidosis, or has received a renal transplant. This defect in renal acidification is thought to reflect inadequate distal Na reaborption. In a normal person this distal Na reaborption creates a negative charge in the tubular lumen which would favor H+ secretion. In hyperkalemic distal RTA, this sodium reabsorption is defective, resulting in defective acidification. The syndrome can be entirely reproduced by giving the diuretic amiloride, which inhibits the conductive type of distal Na reabsorption.

TYPE 4 RTA is extremely common. Anyone with reduced GFR has Type 4 RTA. The disorder is also common in diabetics, and in patients taking nonsteroidal antiinflammatory agents, captopril, or heparin. Patients with Type 4 RTA have inadequate aldosterone support of renal acidification. There are many subtypes including defects in renin production, in aldo production, and in the renal response to aldosterone. A central feature of Type 4 RTA is hyperkalemia. This is the result of defective renal K+ secretion, from the insufficient aldosterone effect. The hyperkalemia in turn depresses renal NH3 formation so much that the normal amount of NAE cannot be achieved.

METABOLIC ALKALOSIS
Metabolic alkalosis represents a primary increase in blood HCO3. This will be due to loss of a strong acid (from the kidney or the GI tract) or occasionally from gain of base if the renal function is so poor that HCO3 excretion is compromised. Because the primary problem is metabolic, the compensation is respiratory. The chemoreceptors respond to metabolic alkosis by depressing ventilation. The pCO2 will rise about 0.8 mM Hg for each mEq/L increase in HCO3. The depression of alveolar ventilation will also produce hypoxemia. As alkalosis becomes severe (pH > 7.65) one starts to see increased neuromuscular irritability in the form of increased reflexes, a tendency to tetany , carpopedal spasm, and cardiac arrythmias. Another problem of alkalemia is it’s tendency to worsen hepatic encephalopathy. This is result of alkalemia shifting the ammonia mass equation towards the uncharged NH3 species which can more readily cross the blood-brain barrier and contribute to encephalopathy:

There is often associated hypokalemia and hypomagnesemia. Both of these may arise from whatever the primary problem was (eg. loses from emesis) or from the hyperaldosteronism that almost always accompanies metabolic alkalosis.
The treatment of metabolic alkalosis always centers on reversing the primary abnormality, correcting volume depletion, and replenishing K and Mg deficits. In emergencies (neuromuscular sx/sns, respiratory depression) one can directly reduce the HCO3 levels by dialysis, by giving acid (as intravenous HCl, arginine HCl, or oral NH4Cl), or by trying to induce a bicarbonate diuresis with the carbonic anhydrase inhibitor acetazolamide (Diamox).

The figure below illustrates how much HCO3 appears in the urine as blood HCO3 is raised from low to high levels by HCO3 infusion. There is no HCO3 in the urine until the “threshold” value is reached at 22-28 mEq/L, at which point urinary HCO3, increases steeply. At these high values of blood HCO3 the nephron’s ability to reclaim HCO3 is simply overwhelmed and the excess will be excreted quantitatively in the urine. Sustained metabolic alkalosis therefore cannot be produced in a normal person by HCO3 infusion. To produce this disorder requires some stimulation of renal H+ secretion, and the two most common causes are mineralocorticoids 9which increase distal acidification) and volume depletion ( which increases proximal acidification). The figure shows that with volume depletion the augmented proximal acidification in effect raises the HCO3 threshold to higher values. Essentially the same pattern is seen with mineralocorticoid excess. Note that if the patient’s HCO3 is below the threshold the urine will be acid.

Differential diagnosis of metabolic alkalosis One classification of metabolic alkalosis is shown in the table. As we have already reviewed, it is difficult to sustain a metabolic alkalosis from alkali administration, although certainly acute disorders can be produced by this mechanism. The differential diagnosis in a patient with established alkalosis therefore is between “chloride-resistant” and “chloride responsive” disorders. This distinction is based on whether or not the alkalosis resolves by simply giving chloride (usually as IV NaCl, although any chloride salt will suffice). We will consider a prototypic example of each: emesis as a model of chloride-responsive alkalosis, and primary aldosteronism as an example of resistant alkalosis.

The distinction between chloride responsive and resistant disorders can be made by observing the response to NaCl volume expansion. It is a bit more elegant to make the diagnosis before starting therapy, and this can be accomplished by measuring urinary chloride. This difference in urinary chloride reflects the major difference in the ECF volume in these two categories: in the chloride-responsive alkaloses there is volume depletion (or chloride depletion). One might expect to see all the signs of volume depletion in terms of orthostasis, decreased turgor, and low urinary Na and Cl. In chloride-resistant alkalosis there is generally ECF volume expansion, resulting in hypertension, possible edema, and generous amounts of urinary Na and Cl.

There are a few pitfalls with using the urinary chloride as a basis of classifying the subtypes of metabolic alkalosis. These are the times when a patient truly has a volume-responsive alkalosis but is having a transient NaCl diuresis from either diuretics or immediately after vomiting. In both cases the urinary chloride will be falsely high during the transient diurese, but will then return to low levels in the steady state.
URINE Cl- < 10 mEq/L = VOLUME – RESPONSIVE ALKALOSIS
GENERATED BY: LOSS OF HCL FORM EMESIS
MAINTAINED BY: VOLUME DEPLETION, K+ DEPLETION
DDX OF
METABOLIC
ALKALOSIS
BASED
ON URINE Cl
URINE Cl- > 20 mEq/L = VOLUME – RESISTANT ALKALOSIS
GENERATED BY: RENAL LOSS OF ACID FROM MINERALOCORTICOID
MAINTAINED BY: SAME, OPPOSED BY VOLUME EXPANSION

Metabolic alkalosis from emesis is extremely common, as you might imagine. The diagnosis is usually evident from the history. Some patients deny vomiting (anorectics, bulimics). In these patients the diagnosis can be made from finding the typical laboratory features of chloride-responsive alkalosis. Sometimes you can also detect covert emesis by taping a dipstick to the back of a tongue-blade and showing acid oral contents on “examining the throat”.
The pathophysiology of this alkalosis is diagrammed below, and centers on the loss of HCl and NaCl in the emesis. This both generates the alkalosis (loss of HCl) and initiates volume depletion and hyperaldosteronism which will perpetuate thealkalosis by augmenting renal H+ secretion and raising the renal HCO3 threshold.
Note that the actual pattern of urine pH and Cl will depend on whether the patient is in the steady state or had just vomited. In the steady state, the patient will have an elevated renal HCO3 threshold. His plasma HCO3 will therefore exist at this threshold value, at which point the remainder of urinary acidification takes place normally, or may even by augmented by aldo. Despite the ongoing alkalosis and elevated blood HCO3, the urine in the steady state situation will be normally acid, and will reveal the low Na and Cl characteristic of the volume-depleted state.

If the patient vomit again, the gastric loss of HCl will transiently elevate blood HCO3 to values just above the renal threshold, which hasn’t had time enough to sense further volume depletion. There will be a transient NaHCO3 and NaCl diuresis which will alkalinize the urine until the blood HCO3 level falls to the new slightly higher threshold value.

Potassium and metabolic alkalosis Potassium is almost always reduced in metabolic alkalosis. As outlined below, there are several reasons for this, including inadequate intake, GI losses in emesis, or renal losses from diuretics, mineralocorticoids, or magnesium depletion. The resulting hypokalemia can in turn contribute to the alkalosis by inducing cellular K+ depletion. This directly stimulates proximal acidification, potentiates aldo effects on distal H+ secretion, and causes immediate H+ shifts in cells. All of these mechanisms will contribute to the alkalosis. In fact, when there is severe K+ depletion, these mechanisms are apparently enough to sustain metabolic alkalosis even in the absence of volume depletion or excessive mineralocorticoids. Certainly K+ therapy is indicated in these cases, as it is in essentially all patients with metabolic alkalosis.
